Toshihiro Matsui Selected Research

1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedione

9/2022	Clinical variables, including novel joint index, associated with future patient-physician discordance in global assessment of rheumatoid arthritis (RA) disease activity based on a large RA database in Japan.
4/2018	Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihiro Matsui Research Topics

Disease

28	Rheumatoid Arthritis 09/2022 - 01/2003
15	Infections 01/2022 - 12/2007
9	Parkinson Disease (Parkinson's Disease) 04/2008 - 08/2003
8	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2012
6	Rheumatic Diseases (Rheumatism) 02/2022 - 07/2006
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2003
5	Neoplasms (Cancer) 05/2021 - 02/2011
4	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2021 - 11/2015
3	Dermatomyositis (Dermatopolymyositis) 11/2022 - 01/2012
3	Neoplasm Metastasis (Metastasis) 08/2020 - 11/2013
2	Polymyositis 11/2022 - 07/2020
2	Pain (Aches) 09/2022 - 06/2018
2	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2021
2	Myositis (Idiopathic Inflammatory Myopathies) 07/2020 - 09/2011
2	Lung Diseases (Lung Disease) 01/2017 - 01/2015
2	Pneumonia (Pneumonitis) 01/2015 - 01/2013
2	Breast Neoplasms (Breast Cancer) 11/2014 - 11/2013
2	Stomach Neoplasms (Stomach Cancer) 11/2013 - 01/2012
2	Brain Ischemia (Cerebral Ischemia) 08/2008 - 07/2005
2	Systemic Scleroderma (Systemic Sclerosis) 06/2007 - 01/2003
1	Mixed Connective Tissue Disease (MCTD) 01/2022
1	Primary Immunodeficiency Diseases 10/2021
1	Leg Ulcer 08/2021
1	Rheumatoid Vasculitis 08/2021
1	Lupus Nephritis 04/2021
1	Esophageal Squamous Cell Carcinoma 11/2020
1	Spontaneous Remission 08/2020
1	Esophageal Neoplasms (Esophageal Cancer) 08/2020
1	Lung Neoplasms (Lung Cancer) 08/2020
1	Drug-Related Side Effects and Adverse Reactions 05/2020
1	Paralysis (Palsy) 10/2019
1	Collagen Diseases (Collagen Disease) 01/2019
1	Vasculitis (Vasculitides) 01/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2018
1	Squamous Cell Carcinoma of Head and Neck 08/2018
1	Thrombotic Microangiopathies 01/2018
1	Hematuria 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Proteinuria 01/2018

Drug/Important Bio-Agent (IBA)

7	Methotrexate (Mexate)FDA LinkGeneric 08/2020 - 11/2013
5	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2022 - 12/2011
5	C-Reactive ProteinIBA 09/2022 - 09/2007
5	AntibodiesIBA 01/2022 - 04/2006
5	Pharmaceutical PreparationsIBA 05/2021 - 01/2009
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2021 - 12/2006
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2006
4	Immunoglobulin G (IgG)IBA 01/2022 - 12/2006
4	GlucocorticoidsIBA 05/2020 - 01/2013
4	Neuroprotective AgentsIBA 08/2008 - 03/2004
3	Rheumatoid FactorIBA 01/2022 - 12/2006
3	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 11/2019
3	Tacrolimus (Prograf)FDA LinkGeneric 05/2021 - 04/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2011
3	HLA Antigens (Human Leukocyte Antigens)IBA 07/2020 - 01/2012
3	Biological ProductsIBA 04/2018 - 12/2006
3	Polysaccharides (Glycans)IBA 12/2015 - 06/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2005 - 03/2004
2	Prostaglandins AIBA 09/2022 - 06/2018
2	1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA 09/2022 - 04/2018
2	N-phthaloylglutamic acidIBA 09/2022 - 06/2018
2	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 12/2006
2	Abatacept (Orencia)FDA Link 05/2021 - 12/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2009
2	InterferonsIBA 07/2016 - 01/2003
2	23-valent pneumococcal capsular polysaccharide vaccineIBA 12/2015 - 06/2015
2	tocilizumab (atlizumab)FDA Link 01/2015 - 01/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2013 - 12/2011
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2013 - 01/2012
2	SteroidsIBA 01/2013 - 01/2012
2	Therapeutic UsesIBA 11/2009 - 01/2008
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2008 - 01/2005
2	cyclic citrullinated peptideIBA 12/2006 - 07/2006
2	Capsules (Microcapsules)IBA 07/2005 - 03/2005
2	AutoantibodiesIBA 01/2003 - 01/2003
1	Branched-Chain Amino AcidsIBA 11/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	cyclo(Arg-Pro) (CI 4)IBA 01/2022
1	RibonucleoproteinsIBA 01/2022
1	HLA-DRB1*04:01 antigenIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2021
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	NF-kappa B (NF-kB)IBA 01/2019
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	Lugol's solution (Lugol's iodine)IBA 08/2018
1	Foscarnet FDA LinkGeneric 01/2018
1	CreatinineIBA 01/2018
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2017

Therapy/Procedure

9	Therapeutics 08/2021 - 01/2003
6	Drug Therapy (Chemotherapy) 01/2017 - 11/2013
3	Cell Transplantation 01/2022 - 08/2003
3	Esophagectomy 11/2020 - 10/2019
3	Transplantation 01/2018 - 01/2005
2	Transitional Care 02/2022 - 11/2018
2	Lymph Node Excision (Lymph Node Dissection) 10/2019 - 11/2013
1	Hematopoietic Stem Cell Transplantation 10/2021